OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
16
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Release Date
2023
(4)
2021
(4)
2025
(3)
2022
(3)
2019
(1)
2017
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Aberrantly activated TAK1 links neuroinflammation and neuronal loss in Alzheimer's disease mouse models.
Not available
S-EPMC10112982
|
biostudies-literature
Cite
Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas.
Not available
S-EPMC6775537
|
biostudies-literature
Cite
VAL-083 is effective in patients with newly-diagnosed MGMT-unmethylated glioblastoma: report of phase II study.
Not available
S-EPMC12816464
|
biostudies-literature
Cite
Genomic landscape and immunological profile of glioblastoma in East Asian patients.
Not available
S-EPMC12432365
|
biostudies-literature
Cite
Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas: A Randomized Clinical Trial.
Not available
S-EPMC11839150
|
biostudies-literature
Cite
Research priorities in Maternal, Newborn, & Child Health & Nutrition for India: An Indian Council of Medical Research-INCLEN Initiative.
Not available
S-EPMC5644295
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607
|
biostudies-literature
Cite
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets